臺灣健保癌症用藥事前審查實作指引
1.0.1 - release
臺灣健保癌症用藥事前審查實作指引
1.0.1 - release
This page is part of the 臺灣癌症用藥事前審查實作指引(TWPAS IG) (v1.0.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
| Official URL: https://twcore.mohw.gov.tw/ig/pas/CodeSystem/nhi-tx-ast | Version: 1.0.1 | |||
| Active as of 2024-12-06 | Computable Name: NHITreatmentAst | |||
臺灣衛生福利部中央健康保險署「治療後疾病狀態評估項目」代碼，代碼出版日期：2024-12-06；資料所屬單位：臺灣衛生福利部中央健康保險署。
This Code system is referenced in the content logical definition of the following value sets:
Generated Narrative: CodeSystem nhi-tx-ast
This case-sensitive code system https://twcore.mohw.gov.tw/ig/pas/CodeSystem/nhi-tx-ast defines the following codes:
| Code | Display |
| ICLL | iwCLL (International Workshop on CLL) |
| IREC | i-RECIST criteria |
| MREC | mRECIST criteria |
| REC1 | RECIST 1.1 criteria |
| IWGC | International Working Group(IWG) Consensus Criteria |